Variation in lipid-associated genes as they relate to risk of advanced age-related macular degeneration

World Review of Nutrition and Dietetics

Volumn 99, Issue , 2009, Pages 105-108

  SanGiovanni, John Paul ^a   Mehta, Sonia ^b   Mehta, Sonul ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; INOSITOL; LIPID; OMEGA 3 FATTY ACID;

AGING; CHEMISTRY; DIET; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; RETINA; RETINA MACULA DEGENERATION; REVIEW;

AGING; DIET; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INOSITOL; LIPIDS; MACULAR DEGENERATION; OXIDATION-REDUCTION; RETINA;

EID: 62449284549     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000193002     Document Type: Article

References (329)

1. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P: Causes and prevalence of visual impairment among adults in the United States. Arch Oph-thalmol 2004;122:477-485.
2. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J: Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564-572.
3. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP: Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Oph-thalmol 2003;48:257-293.
4. Holz FG, Pauleikhoff D, Klein R, Bird AC: Patho-genesis of lesions in late age-related macular disease. Am J Ophthalmol 2004;137:504-510.
5. Moshfeghi DM, Blumenkranz MS: Role of genetic factors and inflammation in age-related macular degeneration. Retina 2007;27:269-275.
6. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45:115-134.
7. Mukherjee PK, Chawla A, Loayza MS, Bazan NG: Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot Essent Fatty Acids 2007;77:233-238.
8. Bazan NG: Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosa-hexaenoic acid: the proctor lecture. Invest Ophthal-mol Vis Sci 2007;48:4864-4881.
9. Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG: Neurotrophins enhance retinal pigment epithelial cell survival through neuropro-tectin D1 signaling. Proc Natl Acad Sci USA 2007; 104:13152-13157.
10. Mukherjee PK, Marcheselli VL, de Rivero Vaccari JC, Gordon WC, Jackson FE, Bazan NG: Photore-ceptor outer segment phagocytosis attenuates oxi-dative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc Natl Acad Sci USA 2007;104:13158-13163.
11. Connor KM, SanGiovanni J P, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N Jr, Serhan CN, Smith LE: Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007;13:868-873.
12. SanGiovanni J P, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, Kurinij N, Lindblad AS, Milton RC, Seddon JM, Sperduto RD: The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No 20. Arch Ophthalmol 2007;125:671-679.
13. SanGiovanni J P, Chew EY: The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005;24:87- 138.
14. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG: Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004;101:8491-8496.
15. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM: A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007;3:e98.
16. Seddon JM, Cote J, Rosner B: Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003;121:1728-1737.
17. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair N P, Willett W: Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191-1199.
18. Smith W, Mitchell P, Leeder SR: Dietary fat and fish intake and age-related maculopathy. Arch Ophthal-mol 2000;118:401-404.
19. Mares-Perlman JA, Brady WE, Klein R, Vanden-Langenberg GM, Klein BE, Palta M: Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-748.
20. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M: Relationship of dietary fat to age-related maculopathy in the third national health and nutrition examination survey. Arch Ophthalmol 2001;119:1833-1838.
21. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE: Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-218.
22. Seddon JM, George S, Rosner B: Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006;124:995-1001.
23. Tan JS, Mitchell P, Kifley A, Flood V, Smith W, Wang JJ: Smoking and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Arch Ophthalmol 2007;125:1089-1095.
24. Arnarsson A, Sverrisson T, Stefansson E, Sigurdsson H, Sasaki H, Sasaki K, Jonasson F: Risk factors for five-year incident age-related macular degeneration: The Reykjavik Eye Study. Am J Ophthalmol 2006; 142:419-428.
25. Delcourt C, Carriere I, Cristol J P, Lacroux A, Ger-ber M: Dietary fat and the risk of age-related macu-lopathy: The Polanut Study. Eur J Clin Nutr 2007;61: 1341-1344.
26. SanGiovanni JP, Chew E, Agrón E, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, Kurinij N, Lindblad AS, Milton RC, Seddon JM, Klein R, Sper-duto RD, AREDS Research Group: The relationship of dietary lipid intake with incident age-related macular degeneration: a prospective study in the Age-Related Eye Disease Study. AREDS Report No 23. Arch Ophthalmol 2008;126:1274-1279.
27. Fliesler SJ, Anderson RE: Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983;22:79-131.
28. Kulkarni P, Cai J, Hurst HE: Lipids and nitric oxide in porcine retinal and choroidal blood vessels. J Ocul Pharmacol Ther 2002;18:265-275.
29. Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M: Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microve-ssels. J Neurochem 1996;66:2160-2167.
30. Serhan CN, Chiang N: Endogenous pro-resolving and anti-inflammatory lipid mediators: a new phar-macologic genus. Br J Pharmacol 2008;153(suppl 1): S200-S215.
31. Bazan NG: The metabolism of omega-3 polyunsat-urated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989;312:95-112.
32. Nettleton JA: Omega-3 Fatty Acids and Health. New York, Chapman & Hall, 1995.
33. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006;83:1483S-1493S.
34. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70:560S- 569S.
35. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Max Snodderly D: Nutritional manipulation of primate retinas. I V. Effects of n-3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region. Exp Eye Res 2005;81:513-529.
36. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM: Nutritional manipulation of primate retinas. II. Effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci 2004;45:3244-3256.
37. Rotstein NP, Aveldano MI, Barrantes FJ, Roccamo AM, Politi LE: Apoptosis of retinal photoreceptors during development in vitro: protective effect of doco-sahexaenoic acid. J Neurochem 1997;69:504-513.
38. Rotstein NP, Politi LE, Aveldano MI: Docosa-hexaenoic acid promotes differentiation of developing photoreceptors in culture. Invest Ophthalmol Vis Sci 1998;39:2750-2758.
39. Rotstein N P, Aveldano MI, Barrantes FJ, Politi LE: Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem 1996;66:1851-1859.
40. Rotstein N P, Politi LE, German OL, Girotti R: Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003;44:2252-2259.
41. Chucair AJ, Rotstein N P, Sangiovanni J P, During A, Chew EY, Politi LE: Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007;48:5168-5177.
42. German OL, Insua MF, Gentili C, Rotstein N P, Politi LE: Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochem 2006;98:1507-1520.
43. Garelli A, Rotstein N P, Politi LE: Docosahexaenoic acid promotes photoreceptor differentiation without altering CRX expression. Invest Ophthalmol Vis Sci 2006;47:3017-3027.
44. Insua MF, Garelli A, Rotstein NP, German OL, Arias A, Politi LE: Cell cycle regulation in retinal progenitors by glia-derived neurotrophic factor and doco-sahexaenoic acid. Invest Ophthalmol Vis Sci 2003; 44:2235-2244.
45. Chow KC: Fatty Acids in Foods and Their Health Implications, ed 2. New York, Dekker, 2000.
46. Bazan NG: Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 2006;29:263-271.
47. Gordon WC, Bazan NG: Retina; in Harding JJ (ed): Biochemistry of the Eye. London, Chapman & Hall, 1997, pp 144-275.
48. Uauy R, Mena P, Rojas C: Essential fatty acids in early life: structural and functional role. Proc Nutr Soc 2000;59:3-15.
49. Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-463.
50. Simopoulos AP: The role of fatty acids in gene expression: health implications. Ann Nutr Metab 1996;40:303-311.
51. Simopoulos AP, Leaf A, Salem N Jr: Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000;63:119-121.
52. Neuringer M: The relationship of fatty acid composition to function in the retina and visual system; in Dobbing J (ed): Lipids, Learning, and the Brain: Fats in Infant Formulas. 103rd Ross Conference on Pediatric Research. Adelaide, South Australia, Ross Laboratories, 1993, pp 134-158.
53. Martinez M, Vazquez E, Garcia-Silva MT, Man-zanares J, Bertran JM, Castello F, Mougan I: Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 2000;71:376S-385S.
54. Salem N Jr, Litman B, Kim HY, Gawrisch K: Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001;36:945-959.
55. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem N Jr, Litman BJ: Reduced G-protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 2004;279:31098-31104.
56. Neuringer M, Jeffrey BG: Visual development: neural basis and new assessment methods. J Pediatr 2003;143:S87-S95.
57. De Caterina R, Madonna R: Nutrients and gene expression. World Rev Nutr Diet. Basel, Karger, 2004, vol 93, pp 99-133.
58. De Caterina R, Madonna R: Role of nutrients and physical activity in gene expression. World Rev Nutr Diet. Basel, Karger, 2005, vol 94, pp 107-119.
59. De Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000;290:2140-2144.
60. Politi L, Rotstein N, Carri N: Effects of docosa-hexaenoic acid on retinal development: cellular and molecular aspects. Lipids 2001;36:927-935.
61. Calder PC: Omega-3 polyunsaturated fatty acids, inflammation and immunity. World Rev Nutr Diet. Basel, Karger, 2001;88:109-116.
62. Nelson GJ: Effects of dietary fatty acids on lipid metabolism; in Chow KC (ed): Fatty Acids in Foods and Their Health Implications. New York, Dekker, 2000, pp 481-516.
63. Daemen FJ: Vertebrate rod outer segment membranes. Biochim Biophys Acta 1973;300:255-288.
64. Choe HG, Anderson RE: Unique molecular species composition of glycerolipids of frog rod outer segments. Exp Eye Res 1990;51:159-165.
65. Wiegand RD, Koutz CA, Stinson AM, Anderson RE: Conservation of docosahexaenoic acid in rod outer segments of rat retina during n-3 and n-6 fatty acid deficiency. J Neurochem 1991;57:1690- 1699.
66. Aveldano MI, Sprecher H: Very long chain (C24 to C36) polyenoic fatty acids of the n-3 and n-6 series in dipolyunsaturated phosphatidylcholines from bovine retina. J Biol Chem 1987;262:1180-1186.
67. Litman BJ, Mitchell DC: A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996;31(suppl):S193-S197.
68. Anderson RE: Lipids of ocular tissues. I V. A comparison of the phospholipids from the retina of six mammalian species. Exp Eye Res 1970;10:339-344.
69. Lands WE: Impact of daily food choices on health promotion and disease prevention. World Rev Nutr Diet. Basel, Karger, 2001, vol 88, pp 1-5.
70. Simopoulos AP: Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60:502-507.
71. Su HM, Bernardo L, Mirmiran M, Ma XH, Corso TN, Nathanielsz PW, Brenna JT: Bioequivalence of dietary α-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr Res 1999;45:87-93.
72. Wetzel MG, Li J, Alvarez RA, Anderson RE, O'Brien PJ: Metabolism of linolenic acid and docosa-hexaenoic acid in rat retinas and rod outer segments. Exp Eye Res 1991;53:437-446.
73. Wang N, Anderson RE: Synthesis of docosa-hexaenoic acid by retina and retinal pigment epithelium. Biochemistry 1993;32:13703-13709.
74. Delton-Vandenbroucke I, Grammas P, Anderson RE: Polyunsaturated fatty acid metabolism in retinal and cerebral microvascular endothelial cells. J Lipid Res 1997;38:147-159.
75. Moore SA: Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neuro-sci 2001;16:195-201.
76. Rodriguez de Turco EB, Parkins N, Ershov AV, Bazan NG: Selective retinal pigment epithelial cell lipid metabolism and remodeling conserves photo-receptor docosahexaenoic acid following phagocytosis. J Neurosci Res 1999;57:479-486.
77. Scott BL, Bazan NG: Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 1989;86:2903-2907.
78. Bazan NG: Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system; in Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain. New York, Raven Press, 1990, vol 8, pp 1-24.
79. Li F, Chen H, Anderson RE: Biosynthesis of docosa-hexaenoate-containing glycerolipid molecular species in the retina. J Mol Neurosci 2001;16:205-221.
80. Anderson GJ, Connor WE: Uptake of fatty acids by the developing rat brain. Lipids 1988;23:286-290.
81. Conquer JA, Holub BJ: Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 1996;126:3032-3039.
82. Conquer JA, Holub BJ: Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997;32:341-345.
83. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Ether-ton TD: Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71:179S-188S.
84. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-2757.
85. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM: n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006;83:1526S-1535S.
86. DHHS/FDA: Department of Health and Human Services, US Food and Drug Administration: Substances affirmed as generally recognized as safe: menhaden oil. Federal Register. June 5, 1997. Vol 62, No 108, pp 30751-30757. 21 cfr part 184. Docket No. 86g-0289. 1997. 2003.
87. DHHS/FDA: Office of Nutritional Products, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, US Food and Drug Administration: Letter responding to a request to reconsider the qualified claim for a dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Docket No. 91n-0103. February 8, 2002. 2002.
88. Vericel E, Calzada C, Chapuy P, Lagarde M: The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 1999;147:187-192.
89. Dyerberg J, Bang HO: Lipid metabolism, atherogen-esis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis 1979;8:227- 233.
90. Von Schacky C, Fischer S, Weber PC: Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985;76:1626-1631.
91. Levine PH, Fisher M, Schneider PB, Whitten RH, Weiner BH, Ockene IS, Johnson BF, Johnson MH, Doyle EM, Riendeau PA, et al: Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 1989;149:1113-1116.
92. Li XL, Steiner M: Dose response of dietary fish oil supplementations on platelet adhesion. Arterioscler Thromb 1991;11:39-46.
93. Jumpsen J, Clandinin MT: Brain Development: Relationship to Dietary Lipid and Lipid Metabolism. Champaign/IL, AOCS Press, 1997.
94. Clandinin MT, Jumpsen J, Suh M: Relationship between fatty acid accretion, membrane composition, and biologic functions. J Pediatr 1994;125:S25- S32.
95. Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR: Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured y-79 retinoblastoma cells. Arch Biochem Biophys 1992;294:564-570.
96. Litman BJ, Niu SL, Polozova A, Mitchell DC: The role of docosahexaenoic acid containing phospho-lipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 2001;16:237-242, 279-284.
97. Niu SL, Mitchell DC, Litman BJ: Manipulation of cholesterol levels in rod disk membranes by methyl-β-cyclodextrin: effects on receptor activation. J Biol Chem 2002;277:20139-20145.
98. Niu SL, Mitchell DC, Litman BJ: Optimization of receptor-G protein coupling by bilayer lipid composition. II. Formation of metarhodopsin ii-transdu-cin complex. J Biol Chem 2001;276:42807-42811.
99. Mitchell DC, Niu SL, Litman BJ: Optimization of receptor-G protein coupling by bilayer lipid composition. I. Kinetics of rhodopsin-transducin binding. J Biol Chem 2001;276:42801-42806.
100. Mitchell DC, Niu SL, Litman BJ: Enhancement of G-protein-coupled signaling by DHA phospholip-ids. Lipids 2003;38:437-443.
101. Doucet JP, Squinto SP, Bazan NG: Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance. Mol Neurobiol 1990;4:27-55.
102. Yaqoob P: Lipids and the immune response. Curr Opin Clin Nutr Metab Care 1998;1:153-161.
103. Miles EA, Calder PC: Modulation of immune function by dietary fatty acids. Proc Nutr Soc 1998;57:277-292.
104. De Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000;290:2140-2144.
105. Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N: Ligand selectivity of the peroxisome proliferator-activated receptor α. Biochemistry 1999;38:185-190.
106. Kim HY, Edsall L: The role of docosahexaenoic acid (22:6n-3) in neuronal signaling. Lipids 1999;34(suppl):S249-S250.
107. 2-mediated neuronal cell death involves glutamate ionotropic receptors. Neu-roreport 2002;13:1963-1966.
108. Phillis J W, O'Regan MH: A potentially critical role of phospholipases in central nervous system isch-emic, traumatic, and neurodegenerative disorders. Brain Res Brain Res Rev 2004;44:13-47.
109. Ju W-K, Kim K-Y, Neufeld AH: Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 2003;77:137-145.
110. Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Alvarez D, Al-Dalain S, Martinez G, Leon OS, Springer JE: Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurode-generation following transient global cerebral ischemia. J Neurochem 2003;86:545-555.
111. Phillis J W, O'Regan MH: The role of phospholi-pases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit Rev Neurobiol 2003;15:61-90.
112. Boulton M, Rózanowska M, Rózanowski B: Retinal photodamage. J Photochem Photobiol B 2001;64: 144-161.
113. Jung H, Reme C: Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release. Graefes Arch Clin Exp Ophthalmol 1994;232:167- 175.
114. Hendrickx N, Volanti C, Moens U, Seternes OM, de Witte P, Vandenheede JR, Piette J, Agostinis P: Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J Biol Chem 2003;278:52231-52239
115. Naveh N, Weissman C, Marshall J: Lipoxygenase metabolism following laser induced retinal injury in rabbits. Curr Eye Res 2000;21:554-559.
116. 2 stimulation in a human keratino-cyte cell line. Adv Exp Med Biol 1997;433:41-45.
117. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleu-kin-1, tumor necrosis factor-α, and lipopolysaccha-ride. J Clin Invest 1995;95:1669-1675.
118. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003;52:2570-2577.
119. Werz O, Szellas D, Steinhilber D: Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line. Eur J Biochem 2000;267:1263-1269.
120. Bizik J, Kankuri E, Ristimaki A, Taieb A, Vapaatalo H, Lubitz W, Vaheri A: Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 2004;11:183-195.
121. Penfold PL, Madigan MC, Gillies MC, Provis JM: Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001;20:385-414.
122. Bazan NG, Colangelo V, Lukiw WJ: Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat 2002;68-69: 197-210.
123. Sennlaub F, Valamanesh F, Vazquez-Tello A, El-Asrar AM, Checchin D, Brault S, Gobeil F, Beau-champ MH, Mwaikambo B, Courtois Y, Geboes K, Varma DR, Lachapelle P, Ong H, Behar-Cohen F, Chemtob S: Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 2003;108:198-204.
124. Bazan HE, Tao Y, DeCoster MA, Bazan NG: Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci 1997;38:2492-2501.
125. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE: Cyclooxyge-nase in biology and disease. FASEB J 1998;12:1063- 1073.
126. Flamand N, Surette ME, Picard S, Bourgoin S, Borgeat P: Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 2002;62:250-256.
127. Balazy M, Nigam S: Aging, lipid modifications and phospholipases - new concepts. Ageing Res Rev 2003;2:191-209.
128. Han JH, Roh MS, Park CH, Park KC, Cho KH, Kim KH, Eun HC, Chung JH: Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts. Mech Ageing Dev 2004; 125:359-366.
129. Nemenoff R, Winitz S, Qian N, Van Putten V, Johnson G, Heasley L: Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 1993;268:1960-1964.
130. 2. J Biol Chem 1994; 269:19480-19487.
131. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ: cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269-278.
132. 2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 1996;271: 27723-27729.
133. 2 phosphoryla-tion is regulated by multiple MAPK family members. FEBS Lett 2000;471:83-88.
134. 2 enzymes present in P388D1 macrophages. J Biol Chem 1996; 271:6758-6765.
135. 2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J Biol Chem 1998;273:606-612.
136. Martin RE: Docosahexaenoic acid decreases phos-pholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res 1998;54:805- 813.
137. FitzGerald GA: COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2003;2:879-890.
138. Ringbom T, Huss U, Stenholm A, Flock S, Skattebol L, Perera P, Bohlin L: COX-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod 2001;64:745-749.
139. Corey EJ, Shih C, Cashman JR: Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 1983;80:3581-3584.
140. Romano M, Claria J: Cyclooxygenase-2 and 5-lipox-ygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy. FASEB J 2003;17:1986-1995.
141. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J: Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23:91-147.
142. Wangsa-Wirawan ND, Linsenmeier RA: Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003;121:547-557.
143. Knapp HR: Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997;65: 1687S-1698S.
144. Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K: Intravenously administered vasodilatory prosta-glandins increase retinal and choroidal blood flow in rats. J Pharmacol Sci 2007;103:103-112.
145. Appel LJ, Miller ER 3rd, Seidler AJ, Whelton PK: Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-1438.
146. Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-533.
147. Agren JJ, Vaisanen S, Hanninen O, Muller AD, Hornstra G: Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or doco-sahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1997;57:419-421.
148. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J: Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997;17:279-286.
149. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65:1645S- 1654S.
150. Jump DB: Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002;13:155-164.
151. Khan JC, Shahid H, Thurlby DA, Bradley M, Clayton DG, Moore AT, Bird AC, Yates JR: Age-related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol 2006;90:29-32.
152. Chen Y, Houghton LA, Brenna JT, Noy N: Docosa-hexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal. J Biol Chem 1996;271:20507-20515.
153. Chen Y, Saari JC, Noy N: Interactions of all-trans-retinol and long-chain fatty acids with interphoto-receptor retinoid-binding protein. Biochemistry 1993;32:11311-11318.
154. Organisciak DT, Darrow RM, Barsalou L, Darrow RA, Kutty RK, Kutty G, Wiggert B: Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci 1998;39:1107-1116.
155. Brenna JT, Diau GY: The influence of dietary doco-sahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 2007;77:247-250.
156. Grynberg A, Demaison L: Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 1996;28:S11-S17.
157. Demaison L, Sergiel J P, Moreau D, Grynberg A: Influence of the phospholipid n-6/n-3 polyunsatu-rated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1994;1227:53-59.
158. Pieri C: Fatty acids and aging; in Chow KC (ed): Fatty Acids in Foods and Their Health Implications. New York, Dekker, 2000, pp 763-776.
159. Yu B P, Yang R: Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis. Ann NY Acad Sci 1996;786:1-11.
160. Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco Gabrieli C: Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-l-carnitine, n-3 fatty acids, and coenzyme q10. Ophthalmologica 2005;219:154-166.
161. Van Kuijk FJ, Buck P: Fatty acid composition of the human macula and peripheral retina. Invest Oph-thalmol Vis Sci 1992;33:3493-3496.
162. Muggli R: n-3 long-chain polyunsaturated fatty acids and vitamin E in cardiovascular disease prevention: epiphenomenon or causal dependency? In Huang YS, Lin SJ, Huang PC (eds): Essential Fatty acids and Eicosanoids - Invited Papers from the Fifth International Congress. Champaign/IL, AOCS Press, 2003, pp 65-70.
163. Mabile L, Piolot A, Boulet L, Fortin LJ, Doyle N, Rodriguez C, Davignon J, Blache D, Lussier-Cacan S: Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr 2001;74:449-456.
164. Wander RC, Du SH, Thomas DR: Influence of long-chain polyunsaturated fatty acids on oxidation of low density lipoprotein. Prostaglandins Leukot Essent Fatty Acids 1998;59:143-151.
165. Mori TA, Puddey IB, Burke V, Croft KD, Dunstan DW, Rivera JH, Beilin LJ: Effect of omega-3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep 2000;5:45-46.
166. Luostarinen R, Saldeen T: Dietary fish oil decreases superoxide generation by human neutrophils: relation to cyclooxygenase pathway and lysosomal enzyme release. Prostaglandins Leukot Essent Fatty Acids 1996;55:167-172.
167. Chen LY, Lawson DL, Mehta JL: Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxyge-nase products and endothelium-derived relaxing factor. Thromb Res 1994;76:317-322.
168. Higgins S, Carroll YL, McCarthy SN, Corridan BM, Roche HM, Wallace JM, O'Brien NM, Morrissey PA: Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. Br J Nutr 2001; 85:23-31.
169. Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K, Sandstad B, Solvoll K, Hal-vorsen B, Arnesen H, Nenseter MS: Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 1997;17:2576-2588.
170. Bonanome A, Biasia F, De Luca M, Munaretto G, Biffanti S, Pradella M, Pagnan A: n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 1996;63:261-266.
171. Ando M, Sanaka T, Nihei H: Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol 1999;10:2177-2184.
172. Vericel E, Polette A, Bacot S, Calzada C, Lagarde M: Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets. J Thromb Haemost 2003;1:566-572.
173. De La Paz M, Anderson RE: Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992;33:3497-3499.
174. Bush RA, Reme CE, Malnoe A: Light damage in the rat retina: the effect of dietary deprivation of n-3 fatty acids on acute structural alterations. Exp Eye Res 1991;53:741-752.
175. Organisciak DT, Darrow RM, Jiang YL, Blanks JC: Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest Oph-thalmol Vis Sci 1996;37:2243-2257.
176. Barbosa-Sicard E, Markovic M, Honeck H, Christ B, Muller DN, Schunck WH: Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem Biophys Res Commun 2005;329:1275-1281.
177. Politi LE, Rotstein NP, Carri NG: Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2001;42:3008-3015.
178. Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE: Essential fatty acids in visual and brain development. Lipids 2001;36:885-895.
179. German OL, Miranda GE, Abrahan CE, Rotstein NP: Ceramide is a mediator of apoptosis in retina photoreceptors. Invest Ophthalmol Vis Sci 2006;47:1658-1668.
180. Calder PC: Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001;36:1007-1024.
181. Sijben J W, Calder PC: Differential immunomodula-tion with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007;66:237-259.
182. Serhan CN: Resolution phase of inflammation: novel endogenous anti-inflammatory and prore-solving lipid mediators and pathways. Annu Rev Immunol 2007;25:101-137.
183. Wallace FA, Miles EA, Calder PC: Activation state alters the effect of dietary fatty acids on pro-inflammatory mediator production by murine mac-rophages. Cytokine 2000;12:1374-1379.
184. Rose DP, Connolly JM: Regulation of tumor angio-genesis by dietary fatty acids and eicosanoids. Nutr Cancer 2000;37:119-127.
185. Nie D, Hillman GG, Geddes T, Tang K, Pierson C, Grignon DJ, Honn KV: Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogen-esis and tumor growth. Cancer Res 1998;58:4047- 4051.
186. Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV: 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun 1995; 211:462-468.
187. Tang DG, Diglio CA, Bazaz R, Honn KV: Transcrip-tional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE. J Cell Sci 1995;108:2629-2644.
188. Liu B, Timar J, Howlett J, Diglio CA, Honn KV: Lipoxygenase metabolites of arachidonic and lino-leic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul 1991;2:1045-1055.
189. Talvani A, Machado FS, Santana GC, Klein A, Bar-celos L, Silva JS, Teixeira MM: Leukotriene B4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun 2002;70:4247- 4253.
190. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC: Distribution of TNF-α and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:168-173.
191. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH: Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 2001;42:1586-1591.
192. Hawrami K, Hitman GA, Rema M, Snehalatha C, Viswanathan M, Ramachandran A, Mohan V: An association in non-insulin-dependent diabetes mel-litus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism. Hum Immunol 1996;46:49-54.
193. Limb GA, Soomro H, Janikoun S, Hollifield RD, Shilling J: Evidence for control of tumour necrosis factor-α (TNF-α) activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin Exp Immunol 1999;115:409-414.
194. Yossuck P, Yan Y, Tadesse M, Higgins RD: Dexame-thasone alters TNF-α expression in retinopathy. Mol Genet Metab 2001;72:164-167.
195. Hughes DA, Southon S, Pinder AC: n-3 polyunsat-urated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996;126:603-610.
196. Baldie G, Kaimakamis D, Rotondo D: Fatty acid modulation of cytokine release from human mono-cytic cells. Biochim Biophys Acta 1993;1179:125- 133.
197. Purasiri P, McKechnie A, Heys SD, Eremin O: Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 1997;92:166-172.
198. Yamashita N, Yokoyama A, Hamazaki T, Yano S: Inhibition of natural killer cell activity of human lymphocytes by eicosapentaenoic acid. Biochem Biophys Res Commun 1986;138:1058-1067.
199. Calder PC, Newsholme EA: Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci (Lond) 1992;82:695-700.
200. Santoli D, Phillips PD, Colt TL, Zurier RB: Suppression of interleukin-2-dependent human T-cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-indepen-dent mechanism of inhibition by the fatty acids. J Clin Invest 1990;85:424-432.
201. Calder PC, Bevan SJ, Newsholme EA: The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 1992;75:108-115.
202. Virella G, Fourspring K, Hyman B, Haskill-Stroud R, Long L, Virella I, La Via M, Gross AJ, Lopes-Virella M: Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes. Clin Immunol Immunopathol 1991;61: 161-176.
203. Khalfoun B, Thibault G, Lacord M, Gruel Y, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapen-taenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T-cell surface activation markers. Scand J Immunol 1996; 43:248-256.
204. Brouard C, Pascaud M: Modulation of rat and human lymphocyte function by n-6 and n-3 poly-unsaturated fatty acids and acetylsalicylic acid. Ann Nutr Metab 1993;37:146-159.
205. Tappia PS, Man WJ, Grimble RF: Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages. Mol Cell Biochem 1995;143:89-98.
206. De Caterina R, Liao JK, Libby P: Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000;71:213S-223S.
207. Eicher SD, McVey DS: Dietary modulation of Kupffer cell and splenocyte function during a Salmonella typhimurium challenge in mice. J Leukoc Biol 1995;58:32-39.
208. D'Ambola JB, Aeberhard EE, Trang N, Gaffar S, Barrett CT, Sherman MP: Effect of dietary n-3 and n-6 fatty acids on in vivo pulmonary bacterial clearance by neonatal rabbits. J Nutr 1991;121:1262- 1269.
209. Joe B, Lokesh BR: Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal mac-rophages. Biochim Biophys Acta 1994;1224:255- 263.
210. Hubbard NE, Somers SD, Erickson KL: Effect of dietary fish oil on development and selected functions of murine inflammatory macrophages. J Leu-koc Biol 1991;49:592-598.
211. Huang SC, Misfeldt ML, Fritsche KL: Dietary fat influences Ia antigen expression and immune cell populations in the murine peritoneum and spleen. J Nutr 1992;122:1219-1231.
212. Sanderson P, MacPherson GG, Jenkins CH, Calder PC: Dietary fish oil diminishes the antigen presentation activity of rat dendritic cells. J Leukoc Biol 1997;62:771-777.
213. Yaqoob P, Calder P: Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995;163:120- 128.
214. Billiar TR, Bankey PE, Svingen BA, Curran RD, West MA, Holman RT, Simmons RL, Cerra FB: Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988;104:343-349.
215. Renier G, Skamene E, DeSanctis J, Radzioch D: Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler Thromb 1993;13:1515-1524.
216. Feng C, Keisler DH, Fritsche KL: Dietary omega-3 polyunsaturated fatty acids reduce IFN-? receptor expression in mice. J Interferon Cytokine Res 1999; 19:41-48.
217. Grimm H, Tibell A, Norrlind B, Blecher C, Wilker S, Schwemmle K: Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr 1994;18:417-421.
218. Peterson LD, Jeffery NM, Thies F, Sanderson P, Newsholme EA, Calder PC: Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 1998; 33:171-180.
219. Meydani SN, Yogeeswaran G, Liu S, Baskar S, Mey-dani M: Fish oil and tocopherol-induced changes in natural killer cell-mediated cytotoxicity and PGE2 synthesis in young and old mice. J Nutr 1988;118: 1245-1252.
220. Yaqoob P, Newsholme EA, Calder PC: Inhibition of natural killer cell activity by dietary lipids. Immunol Lett 1994;41:241-247.
221. Sanderson P, Yaqoob P, Calder PC: Dietary lipid modulation of cell-mediated immunity in the rat. Biochem Soc Trans 1995;23:273S.
222. Fritsche KL, Cassity NA: Dietary n-3 fatty acids reduce antibody-dependent cell cytotoxicity and alter eicosanoid release by chicken immune cells. Poult Sci 1992;71:1646-1657.
223. Jolly CA, Jiang YH, Chapkin RS, McMurray DN: Dietary n-3 polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and cer-amide. J Nutr 1997;127:37-43.
224. Sanderson P, Thies F, Calder PC: Extracellular release of free fatty acids by rat T lymphocytes is stimulus-dependent and is affected by dietary lipid manipulation. Cell Biochem Funct 2000;18:47-58.
225. Yaqoob P, Newsholme EA, Calder PC: Fatty acid oxidation by lymphocytes. Biochem Soc Trans 1994; 22:116S.
226. Yaqoob P, Newsholme EA, Calder PC: The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 1994;82:603-610.
227. Yaqoob P, Calder PC: The effects of dietary lipid manipulation on the production of murine T-cell-derived cytokines. Cytokine 1995;7:548-553.
228. Alexander NJ, Smythe NL: Dietary fat modulation of in vitro lymphocyte function. Ann Nutr Metab 1988;32:192-199.
229. Kelley DS, Nelson GJ, Serrato CM, Schmidt PC, Branch LB: Effects of type of dietary fat on indices of immune status of rabbits. J Nutr 1988;118:1376- 1384.
230. Fritsche KL, Cassity NA, Huang SC: Effect of dietary fat source on antibody production and lymphocyte proliferation in chickens. Poult Sci 1991;70:611- 617.
231. Kuratko CN: Proliferation of colonic lymphocytes in response to inflammatory cytokines is lower in mice fed fish oil than in mice fed corn oil. Cancer Lett 2000;148:27-32.
232. Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC: Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 2001;69:449-457.
233. Wallace FA: Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leu-koc Biol 2001;69:449-457.
234. Schmidt EB, Pedersen JO, Ekelund S, Grunnet N, Jersild C, Dyerberg J: Cod liver oil inhibits neutro-phil and monocyte chemotaxis in healthy males. Atherosclerosis 1989;77:53-57.
235. Schmidt EB, Varming K, Pedersen JO, Lervang HH, Grunnet N, Jersild C, Dyerberg J: Long-term supplementation with n-3 fatty acids. II. Effect on neu-trophil and monocyte chemotaxis. Scand J Clin Lab Invest 1992;52:229-236.
236. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lon-nemann G, van der Meer J W, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-271.
237. Schmidt EB, Varming K, Moller JM, Bulow Pedersen I, Madsen P, Dyerberg J: No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest 1996;56:87-92.
238. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC: Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 years. Am J Clin Nutr 2001;73:539- 548.
239. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL: Oral n-3 fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991;121:547-555.
240. Molvig J, Pociot F, Worsaae H, Wogensen LD, Baek L, Christensen P, Mandrup-Poulsen T, Andersen K, Madsen P, Dyerberg J, et al: Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1β content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 1991;34:399-410.
241. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ: The effect on human tumor necrosis factor-α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-122.
242. Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, Firenze C, Alberti A, Di Benedetto D, Stragliotto E: Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of ms patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neu-roimmunol 1995;56:143-153.
243. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC: Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mono-nuclear cell fatty acid compositions but not mono-nuclear cell functions. Eur J Clin Invest 2000;30:260-274.
244. Cooper AL, Gibbons L, Horan MA, Little RA, Roth-well NJ: Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin Nutr 1993;12:321-328.
245. Blok WL, Deslypere JP, Demacker PN, van der Ven-Jongekrijg J, Hectors MP, van der Meer J W, Katan MB: Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur J Clin Invest 1997;27:1003-1008.
246. Cannon JG, Fiatarone MA, Meydani M, Gong J, Scott L, Blumberg JB, Evans WJ: Aging and dietary modulation of elastase and interleukin-1β secretion. Am J Physiol 1995;268:R208-R213.
247. Meydani SN, Lichtenstein AH, Cornwall S, Mey-dani M, Goldin BR, Rasmussen H, Dinarello CA, Schaefer EJ: Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993;92:105-113.
248. Gottlicher M, Demoz A, Svensson D, Tollet P, Berge RK, Gustafsson JA: Structural and metabolic requirements for activators of the peroxisome pro-liferator-activated receptor. Biochem Pharmacol 1993;46:2177-2184.
249. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, Wahli W: Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors. Biol Cell 1993;77:67-76.
250. Yu K, Bayona W, Kallen CB, Harding H P, Ravera CP, McMahon G, Brown M, Lazar MA: Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995;270: 23975-23983.
251. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, Desreumaux P: Role of peroxisome pro-liferator-activated receptor ? and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 2002;360:1410-1418.
252. Jump DB: Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004;41:41-78.
253. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP: Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J 2002; 16:438-440.
254. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 1993;92:2889-2896.
255. Rose DP, Connolly JM, Rayburn J, Coleman M: Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst 1995;87:587-592.
256. Rose D P, Connolly JM: Antiangiogenicity of doco-sahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999;15:1011-1015.
257. Badawi AF, El-Sohemy A, Stephen LL, Ghoshal AK, Archer MC: The effect of dietary n-3 and n-6 poly-unsaturated fatty acids on the expression of cycloox-ygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis 1998;19:905-910.
258. Hamid R, Singh J, Reddy BS, Cohen LA: Inhibition by dietary menhaden oil of cyclooxygenase-1 and -2 in N-nitrosomethylurea-induced rat mammary tumors. Int J Oncol 1999;14:523-528.
259. Ayalasomayajula S P, Kompella UB: Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur J Pharmacol 2003;458:283- 289.
260. Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD: Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia. Invest Ophthalmol Vis Sci 2002;43:1546-1557.
261. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311.
262. 2. Proc Natl Acad Sci USA 1989; 86:1573-1577.
263. Szymczak M, Murray M, Petrovic N: Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 2008; 111:3514-3521.
264. Pehowich DJ: Dietary n-3 fatty acids alter angio-tensin-induced contraction and 1,2-diacylglycerol fatty acid composition in thoracic aortas from diabetic rats. Prostaglandins Leukot Essent Fatty Acids 1998;58:301-309.
265. Murota SI, Onodera M, Morita I: Regulation of angiogenesis by controlling VEGF receptor. Ann NY Acad Sci 2000;902:208-213.
266. Kanayasu T, Morita I, Nakao-Hayashi J, Ito H, Murota S: Enhancement of migration in bovine endothelial cells by eicosapentaenoic acid pretreat-ment. Atherosclerosis 1991;87:57-64.
267. 2 in cultured granulosa-luteal cells. Mol Hum Reprod 2002; 8:992-997.
268. Nakata H, Uemura Y, Kobayashi M, Harada R, Taguchi H: Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granu-locyte macrophage-colony stimulating factor in lung cancer cells. Cancer Sci 2003;94:173-180.
269. Cammisotto PG, Gelinas Y, Deshaies Y, Bukowiecki LJ: Regulation of leptin secretion from white adipo-cytes by free fatty acids. Am J Physiol 2003;285: E521-E526.
270. Reseland JE, Haugen F, Hollung K, Solvoll K, Hal-vorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA: Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001;42:743-750.
271. Nitta K, Uchida K, Tsutsui T, Honda K, Kawashima A, Yumura W, Nihei H: Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cells. Am J Nephrol 1998;18:164-170.
272. Hida M, Fujita H, Ishikura K, Omori S, Hoshiya M, Awazu M: Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-β in mesangial cells. J Cell Physiol 2003;196: 293-300.
273. Kohno M, Yasunari K, Minami M, Kano H, Maeda K, Yoshikawa J: Suppression by eicosapentaenoic acid of oxidized low-density lipoprotein and lysophosphati-dylcholine-induced migration in cultured rat vascular smooth muscle cells. Metabolism 2000; 49:560-562.
274. Yu W, Murray NR, Weems C, Chen L, Guo H, Ethridge R, Ceci JD, Evers BM, Thompson EA, Fields AP: Role of cyclooxygenase-2 in protein kinase C β II-mediated colon carcinogenesis. J Biol Chem 2003;278:11167-11174.
275. Trebble T, Arden NK, Stroud MA, Wootton SA, Burdge GC, Miles EA, Ballinger AB, Thompson RL, Calder PC: Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr 2003;90:405-412.
276. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR: Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003;168:1181-1189.
277. Babcock TA, Helton WS, Hong D, Espat NJ: Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-α production. Surg Infect (Larchmt) 2002;3:145-149.
278. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY: Docosa-hexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in MRNA abundance for both TNF-α and inducible nitric oxide synthase. J Am Soc Nephrol 2003;14:389-396.
279. Tsuji M, Murota SI, Morita I: Docosapentaenoic acid (22:5,n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids 2003;68:337-342.
280. Zhang Y W, Yao XS, Murota S, Morita I: Inhibitory effects of eicosapentaenoic acid on the hypoxia/reoxy-genation-induced tyrosine kinase activation in cultured human umbilical vein endothelial cells. Prostaglandins Leukot Essent Fatty Acids 2002;67: 253-261.
281. Tevar R, Jho DH, Babcock T, Helton WS, Espat NJ: Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metasta-sizing malignancy. JPEN J Parenter Enteral Nutr 2002;26:285-289.
282. Rose D P, Connolly JM: Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999; 83:217-244.
283. Yang S P, Morita I, Murota SI: Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells. J Cell Physiol 1998;176:342-349.
284. Mukutmoni M, Hubbard NE, Erickson KL: Prosta-glandin E2 modulation of vascular endothelial growth factor production in murine macrophages. Prosta-glandins Leukot Essent Fatty Acids 2001; 65: 123-131.
285. Aiello L P, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 2000;77:S113-S119.
286. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
287. Smith LE: Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 2002;91:26-28.
288. Lu M, Adamis AP: Vascular endothelial growth factor gene regulation and action in diabetic retinopa-thy. Ophthalmol Clin North Am 2002;15:69-79.
289. Aiello LP: Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 1997;8:19-31.
290. Kanayasu T, Morita I, Nakao-Hayashi J, Asuwa N, Fujisawa C, Ishii T, Ito H, Murota S: Eicosapen-taenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids 1991;26:271-276.
291. Von Knethen A, Callsen D, Brune B: Superoxide attenuates macrophage apoptosis by NF-κB and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 1999;163:2858-2866.
292. Abribat T, Nedelec B, Jobin N, Garrel DR: Decreased serum insulin-like growth factor-1 in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support. Crit Care Med 2000;28:2366-2372.
293. Akbar M, Kim HY: Protective effects of docosa-hexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 2002;82:655-665.
294. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE: Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98:5804-5808.
295. Kumar S, Boehm J, Lee JC: P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2:717-726.
296. Bogatcheva N V, Dudek SM, Garcia JG, Verin AD: Mitogen-activated protein kinases in endothelial pathophysiology. J Investig Med 2003;51:341-352.
297. Morita I, Zhang Y W, Murota SI: Eicosapentaenoic acid protects endothelial cell function injured by hypoxia/ reoxygenation. Ann NY Acad Sci 2001;947: 394-397.
298. Du Toit PJ, van Aswegen CH, du Plessis DJ: The effect of essential fatty acids on growth and uroki-nase-type plasminogen activator production in human prostate DU-145 cells. Prostaglandins Leu-kot Essent Fatty Acids 1996;55:173-177.
299. McGuire PG, Jones TR, Talarico N, Warren E, Das A: The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. Invest Ophthalmol Vis Sci 2003;44:2736-2742.
300. Pakala R, Radcliffe JD, Benedict CR: Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 1999;60:115-123.
301. Pakala R, Sheng WL, Benedict CR: Serotonin fails to induce proliferation of endothelial cells preloaded with eicosapentaenoic acid and docosahexaenoic acid. Atherosclerosis 1999;145:137-146.
302. Dominguez Z, Merhi-Soussi F, MacOvschi O, Nemoz G, Lagarde M, Prigent AF: Endothelial cell prostacy-clin synthesis induced by lymphocytes is independent of the membrane fatty acid composition of both cell types and of E-selectin, VCAM-1 or ICAM-1-medi-ated adhesion. Br J Haematol 2001; 113:521-532.
303. Collie-Duguid ES, Wahle KW: Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996;220:969-974.
304. Sivak JM, Fini ME: MMPS in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002;21:1-14.
305. Majka S, McGuire P, Colombo S, Das A: The balance between proteinases and inhibitors in a murine model of proliferative retinopathy. Invest Ophthal-mol Vis Sci 2001;42:210-215.
306. Majka S, McGuire PG, Das A: Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 2002;43:260-266.
307. Harris MA, Hansen RA, Vidsudhiphan P, Koslo JL, Thomas JB, Watkins BA, Allen KG: Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglan-dins and matrix metalloproteinase production. Pros-taglandins Leukot Essent Fatty Acids 2001;65:23-29.
308. Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, Moore MA, Yazawa K, Araki E, Tsuda H: Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer 1997;73:607-612.
309. Liu XH, Rose DP: Suppression of type IV collage-nase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo. Cancer Lett 1995;92:21-26.
310. Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, Schiffrin EL: PPAR-α activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002;40:866-871.
311. Hirafuji M, Machida T, Hamaue N, Minami M: Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci 2003;92:308-316.
312. Hirafuji M, Machida T, Tsunoda M, Miyamoto A, Minami M: Docosahexaenoic acid potentiates interleukin-1β induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells. Br J Pharmacol 2002;136:613-619.
313. Curtis CL, Rees SG, Little CB, Flannery CR, Hughes CE, Wilson C, Dent CM, Otterness IG, Harwood JL, Caterson B: Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum 2002;46:1544-1553.
314. Grynberg A, Fournier A, Sergiel JP, Athias P: Membrane docosahexaenoic acid vs. eicosapentaenoic acid and the beating function of the cardiomyocyte and its regulation through the adrenergic receptors. Lipids 1996;31(suppl):S205- S210.
315. Kim HY, Akbar M, Kim KY: Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J Mol Neu-rosci 2001;16:223-227, 279-284.
316. El-seweidy MM, El-swefy SE, Ameen RS, Hashem RM: Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glyca-tion, oxidative stress and cytokine production in STZ diabetic rats. Pharmacol Res 2002;45:391-398.
317. Kaur M, Kaur J, Ojha S, Mahmood A: Dietary fat effects on brush border membrane composition and enzyme activities in rat intestine. Ann Nutr Metab 1996;40:269-276.
318. Klein RJ, Zeiss C, Chew EY, Tsai J Y, Sackler RS, Haynes C, Henning AK, SanGiovanni J P, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J: Complement factor h polymorphism in age-related macular degeneration. Science 2005;308:385-389.
319. AREDS Research Group: The Age-Related Eye Disease Study (AREDS): Design implications. AREDS Report No 1. Control Clin Trials 1999;20:573-600.
320. Ross RJ, Verma V, Rosenberg KI, Chan CC, Tuo J: Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol 2007;2:443-457.
321. Leveziel N, Souied EH, Richard F, Barbu V, Zour-dani A, Morineau G, Zerbib J, Coscas G, Soubrane G, Benlian P: PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007;13:2153-2159.
322. Deangelis MM, Ji F, Adams S, Morrison MA, Harring AJ, Sweeney MO, Capone A Jr, Miller JW, Dryja TP, Ott J, Kim IK: Alleles in the HTRA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 2008;115: 1209-1215.
323. Itoh T, Takenawa T: Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling. Cell Signal 2002;14:733-743.
324. Lemmon MA: Pleckstrin homology domains and phosphoinositides. Biochem Soc Symp 2007:81-93.
325. Hawkins PT, Stephens LR: PI3kγ is a key regulator of inflammatory responses and cardiovascular homeostasis. Science 2007;318:64-66.
326. Akbar M, Calderon F, Wen Z, Kim HY: Docosa-hexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005;102:10858-10863.
327. Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L, Chastre E, Khan F, Lande-gren U, Soderberg O, Bootman MD, Roderick HL: Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci USA 2008; 105:2427-2432.
328. Siddiqui RA, Harvey KA, Zaloga GP: Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Bio-chem 2008;19:417-437.
329. Jude S, Roger S, Martel E, Besson P, Richard S, Bougnoux P, Champeroux P, Le Guennec JY: Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 2006;90:299-325.